Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Raskin Gregory S — Y-mAbs Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Raskin Gregory S

Raskin Gregory S

Director at Y-mAbs Therapeutics, Inc. · on record since Sep 20, 2018

Insider trading activity of Raskin Gregory S

Transactions on record: 2; since Jun 14, 2019

Open-market buys: 0

Open-market sells: 1; $157K

Companies traded: 1; last filing Aug 29, 2019

Figures computed from official regulatory filings — methodology.

Companies where Raskin Gregory S has traded

Y-mAbs Therapeutics, Inc.2 tx · $157K · Aug 29, 2019

Track record of Raskin Gregory S

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Raskin Gregory S

Co-insiders of Raskin Gregory S

Ahmed MahiuddinY-mAbs Therapeutics, Inc.
Ber GerardY-mAbs Therapeutics, Inc.
Buschle MichaelY-mAbs Therapeutics, Inc.
Gad ThomasY-mAbs Therapeutics, Inc.
Gentilcore Douglas JY-mAbs Therapeutics, Inc.
GILL DAVID NY-mAbs Therapeutics, Inc.
Hamill LauraY-mAbs Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

HEALY JAMESY-mAbs Therapeutics, Inc.

Herman Philip KarlY-mAbs Therapeutics, Inc.

Juan Moller San Pedro ClausY-mAbs Therapeutics, Inc.

Kruse BoY-mAbs Therapeutics, Inc.

LaRocca JohnY-mAbs Therapeutics, Inc.

Lisby SteenY-mAbs Therapeutics, Inc.

Lund-Hansen TorbenY-mAbs Therapeutics, Inc.

PFREUNDSCHUH PETER P.Y-mAbs Therapeutics, Inc.

Rajah VigneshY-mAbs Therapeutics, Inc.

Rossi Michael JY-mAbs Therapeutics, Inc.

Smith Susan LauraY-mAbs Therapeutics, Inc.

TAGLIAFERRI MARYY-mAbs Therapeutics, Inc.

TYAGI ASHUY-mAbs Therapeutics, Inc.

Wedell-Wedellsborg JohanY-mAbs Therapeutics, Inc.

WG Biotech ApSY-mAbs Therapeutics, Inc.

Wilms JorisY-mAbs Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Y-mAbs Therapeutics, Inc.	Aug 29, 2019	Sell	-5,882	26.70 USD	$157K	SEC
Y-mAbs Therapeutics, Inc.	Jun 14, 2019	AwardD	16,000	0.00 USD	$0	SEC